Molecular Diagnostics 2008

Theme "Accurate and Early Diagnosis of Life-threatening Diseases "

Molecular diagnostics has been emerging as a field that promises to renew technological progress in the clinical laboratory and vastly improve patient care. It has begun to overcome the impediments of incomplete genetic knowledge, the development of new technology platforms, and the communication of their use and efficacy to lab personnel and clinicians alike.

This Congress and Expo is organized by BITlifesciences, dedicated to build a platform of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technology. CEMD-2008 will also provide an integral forum for leaders in trends of MD, in major diseases treatment to share ideas, network with other delegates, deliver new products and advance understanding of the potential of new molecular diagnostics technologies.

CEMD-2008 plans to:
• Invite 10-15 High Profile speakers from leading company of Diagnostics as plenary lecturers
• Integrate 100-150 scientific and technological presentations at the scientific program and workshops
• Organize 150-200 exhibitors and posters to showcase your current work and new products
• Schedule many opportunities for your company’s products introduction with the customers
• Assemble 1000 professionals of clinical laboratory department from the hospitals in China to visit the exhibition

Who Should Attend

• Molecular diagnostics companies.

• In vitro diagnostic companies.

• Biotechnology companies.

• Medical devices manufacturers.

• Molecular diagnostic laboratorians.

• Laboratory leaders

• Hospital CFOs and CSOs

• Clinical Laboratories Researcher

• Venture capital firms

Why Attend
• Discover the molecular diagnostics sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success.

• Evaluate the competitive dynamics of the molecular diagnostics market and understand the changing relationship between IVD companies and the molecular diagnostics testing sector.

• Identify the key players in the molecular diagnostics market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players.

• Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.

• Understand the factors driving growth of the molecular diagnostics market, which represents over 30% of global in vitro diagnostics sales.

Helen Zhao
Program Leader
Organizing Committee of the CEMD-2008
26 Gaoneng St., R405
Dalian Hightech Zone
Dalian , LN 116025, China
Tel: 0086-411-84799479
Fax: 0086-411-84799629
Email: [email protected]

http://www.sciencealert.com.au/viewevents/highlightedpremierevent.php?ur...